HelixNano Competitors and Similar CompaniesClear all
HelixNano's competitors and similar companies include Eutropics, ONK Therapeutics and Arranta Bio MA.
 HelixNano HelixNano (also known as Helix Nanotechnologies) is a biotechnology company that develops an mRNA platform. |  Eutropics Eutropics Pharmaceuticals is a company that develops predictive diagnostic tests for guiding patient cancer treatments. |  ONK Therapeutics ONK Therapeutics is a company that develops natural killer cell-based therapies intended to target blood cancer with unmet needs. |  Arranta Bio MA Arranta Bio MA is a contract development and manufacturing organization that focuses on serving companies that develop therapies targeting the human microbiome. | |
Founding Date | Founding Date 2013 | Founding Date 2005 | Founding Date 2015 | Founding Date 2019 |
Type | Type Private | Type Private | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations Cambridge, US HQ | Locations Cambridge, US HQ | Locations Barna, IE HQ | Locations Watertown, US HQ Gainesville, US |
Employees | Employees 248% decrease | Employees 5 | Employees 176% decrease | Employees 753% increase |
Funding | ||||
Latest funding round | Latest funding round $ 50k (about 6 years ago) | Latest funding round N/A | Latest funding round $ 8m (over 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 6.4m | Total funding raised N/A | Total funding raised $ 14.6m | Total funding raised $ 82m |
For sources of this data, please see the company profile
View Company Profiles
Eutropics
HQ
Cambridge, US
Employees
5
Eutropics Pharmaceuticals is a company that develops predictive diagnostic tests for guiding patient cancer treatments.
View companyONK Therapeutics
HQ
Barna, IE
Employees
17↓ 6% decrease
ONK Therapeutics is a company that develops natural killer cell-based therapies intended to target blood cancer with unmet needs.
View companyArranta Bio MA
HQ
Watertown, US
Arranta Bio MA is a contract development and manufacturing organization that focuses on serving companies that develop therapies targeting the human microbiome.
View company